<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6559">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03021538</url>
  </required_header>
  <id_info>
    <org_study_id>LungTxECMOvCPB2017</org_study_id>
    <nct_id>NCT03021538</nct_id>
  </id_info>
  <brief_title>Bypass vs. Ecmo in Lung Transplantation (BELT)</brief_title>
  <acronym>BELT</acronym>
  <official_title>Randomized Clinical Trial of Intraoperative Extracorporeal Membrane Oxygenation (ECMO) Versus Cardiopulmonary Bypass (CPB) in Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <brief_summary>
    <textblock>
      This study seeks to determine if ECMO compared to cardiopulmonary bypass during lung
      transplantation has a beneficial effect on short-term outcomes after lung transplantation.
      We hypothesize that ECMO will have decreased transfusion requirements, intubation time,
      lesser primary graft dysfunction with no increase in major adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2017</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding, total number of pRBC transfusion</measure>
    <time_frame>72 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mechanical Ventilation Time (days)</measure>
    <time_frame>30 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative pRBC transfusion rates</measure>
    <time_frame>Intraoperative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary Graft Dysfunction (pgd grade)</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion requirement of FFP, platelets, cryoprecipitate</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite outcome of 30 day mortality, bleeding requiring reoperation, new ECMO, new renal failure requiring dialysis</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Compare Outcomes of Lung Transplant Using Extracorporeal Membrane Oxygenation Versus Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>Cardiopulmonary Bypass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>There will be 40 patients placed on cardiopulmonary bypass during lung transplantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extracorporeal Membrane Oxygenation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There will be 40 patients placed on ECMO during lung transplantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal Membrane Oxygenation</intervention_name>
    <arm_group_label>Extracorporeal Membrane Oxygenation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiopulmonary Bypass</intervention_name>
    <arm_group_label>Cardiopulmonary Bypass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. The study population will be all patients requiring cardiopulmonary support while
        undergoing lung transplantation at our institution.

        Exclusion Criteria:

          1. Patients undergoing concomitant cardiac operations with indication for obligate use
             of cardiopulmonary bypass

          2. Patient with specific anatomy that require full cardiac decompression such as severe
             pulmonary hypertension or large heart that are shifted severely into the left chest

          3. Patients with high likelihood of significant pleural bleeding that will require
             returning the blood back into the cardiotomy reservoir

          4. Patients bridged to transplant with ECMO

          5. Cystic fibrosis/bronchiectasis/resistant infection patients where surgeon will need
             to remove both lungs prior to implantation

          6. Patients who the surgeon feels would be better served with CPB rather than ECMO-
             These patients will be entered into a registry and followed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Tong, M.D., M.B.A.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Tong, M.D., M.B.A.</last_name>
    <phone>216-445-0807</phone>
    <email>tongz@ccf.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefana Rafiroiu, M.S.</last_name>
    <email>rafiros@ccf.org</email>
  </overall_contact_backup>
  <reference>
    <citation>Hoechter DJ, von Dossow V, Winter H, MÃ¼ller HH, Meiser B, Neurohr C, Behr J, Guenther S, Hagl C, Schramm R. The Munich Lung Transplant Group: Intraoperative Extracorporeal Circulation in Lung Transplantation. Thorac Cardiovasc Surg. 2015 Dec;63(8):706-14. doi: 10.1055/s-0035-1556873. Epub 2015 Aug 20.</citation>
    <PMID>26291747</PMID>
  </reference>
  <reference>
    <citation>Ius F, Kuehn C, Tudorache I, Sommer W, Avsar M, Boethig D, Fuehner T, Gottlieb J, Hoeper M, Haverich A, Warnecke G. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012 Dec;144(6):1510-6. doi: 10.1016/j.jtcvs.2012.07.095. Epub 2012 Aug 31.</citation>
    <PMID>22944092</PMID>
  </reference>
  <reference>
    <citation>Bermudez CA, Shiose A, Esper SA, Shigemura N, D'Cunha J, Bhama JK, Richards TJ, Arlia P, Crespo MM, Pilewski JM. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation. Ann Thorac Surg. 2014 Dec;98(6):1936-42; discussion 1942-3. doi: 10.1016/j.athoracsur.2014.06.072. Epub 2014 Oct 22.</citation>
    <PMID>25443002</PMID>
  </reference>
  <reference>
    <citation>Machuca TN, Collaud S, Mercier O, Cheung M, Cunningham V, Kim SJ, Azad S, Singer L, Yasufuku K, de Perrot M, Pierre A, McRae K, Waddell TK, Keshavjee S, Cypel M. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg. 2015 Apr;149(4):1152-7. doi: 10.1016/j.jtcvs.2014.11.039. Epub 2014 Nov 21.</citation>
    <PMID>25583107</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 12, 2017</lastchanged_date>
  <firstreceived_date>January 12, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Michael Zhen-Yu Tong, MD</investigator_full_name>
    <investigator_title>Cardiac Surgeon</investigator_title>
  </responsible_party>
  <keyword>Cardiopulmonary Bypass</keyword>
  <keyword>Extracorporeal Membrane Oxygenation</keyword>
  <keyword>Primary Graft Dysfunction</keyword>
  <keyword>Hemorrhage</keyword>
  <keyword>Mechanical Ventilator</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
